These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 19492488

  • 1. SSRI antidepressants and persistent pulmonary hypertension in newborns.
    Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
    Favrelière S, Nourrisson A, Jaafari N, Pérault Pochat MC.
    Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
    [Abstract] [Full Text] [Related]

  • 3. Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis.
    Masarwa R, Bar-Oz B, Gorelik E, Reif S, Perlman A, Matok I.
    Am J Obstet Gynecol; 2019 Jan; 220(1):57.e1-57.e13. PubMed ID: 30170040
    [Abstract] [Full Text] [Related]

  • 4. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA.
    N Engl J Med; 2006 Feb 09; 354(6):579-87. PubMed ID: 16467545
    [Abstract] [Full Text] [Related]

  • 5. SSRI antidepressants and birth defects.
    Prescrire Int; 2006 Dec 09; 15(86):222-3. PubMed ID: 17167929
    [Abstract] [Full Text] [Related]

  • 6. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I, Koren G, Rovet J, Barrera M, Pulver A, Streiner D, Feldman B.
    Am J Psychiatry; 2012 Nov 09; 169(11):1165-74. PubMed ID: 23128923
    [Abstract] [Full Text] [Related]

  • 7. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN, Bos AF.
    Ned Tijdschr Geneeskd; 2007 Dec 29; 151(52):2873-4. PubMed ID: 18257430
    [Abstract] [Full Text] [Related]

  • 8. SSRI antidepressants: persistent pulmonary hypertension in newborns (continued).
    Prescrire Int; 2012 Oct 29; 21(131):241. PubMed ID: 23189379
    [No Abstract] [Full Text] [Related]

  • 9. Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn: An Update Meta-Analysis.
    Ng QX, Venkatanarayanan N, Ho CYX, Sim WS, Lim DY, Yeo WS.
    J Womens Health (Larchmt); 2019 Mar 29; 28(3):331-338. PubMed ID: 30407100
    [Abstract] [Full Text] [Related]

  • 10. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
    Bérard A, Sheehy O, Zhao JP, Vinet É, Bernatsky S, Abrahamowicz M.
    Br J Clin Pharmacol; 2017 May 29; 83(5):1126-1133. PubMed ID: 27874994
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine during pregnancy: impact on fetal development.
    Morrison JL, Riggs KW, Rurak DW.
    Reprod Fertil Dev; 2005 May 29; 17(6):641-50. PubMed ID: 16263070
    [Abstract] [Full Text] [Related]

  • 12. Safety of newer antidepressants in pregnancy.
    Way CM.
    Pharmacotherapy; 2007 Apr 29; 27(4):546-52. PubMed ID: 17381382
    [Abstract] [Full Text] [Related]

  • 13. [Neonatal outcome after exposure to selective serotonin reuptake inhibitors late in pregnancy].
    Cissoko H, Swortfiguer D, Giraudeau B, Jonville-Béra AP, Autret-Leca E.
    Arch Pediatr; 2005 Jul 29; 12(7):1081-4. PubMed ID: 15964522
    [Abstract] [Full Text] [Related]

  • 14. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.
    Ferreira E, Carceller AM, Agogué C, Martin BZ, St-André M, Francoeur D, Bérard A.
    Pediatrics; 2007 Jan 29; 119(1):52-9. PubMed ID: 17200271
    [Abstract] [Full Text] [Related]

  • 15. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D, Brownell M, Chateau D, Ruth C, Katz LY.
    BMJ Open; 2016 Nov 29; 6(11):e013293. PubMed ID: 27899401
    [Abstract] [Full Text] [Related]

  • 16. The effect of perinatal exposures on the infant: antidepressants and depression.
    Hanley GE, Oberlander TF.
    Best Pract Res Clin Obstet Gynaecol; 2014 Jan 29; 28(1):37-48. PubMed ID: 24100223
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
    Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.
    J Clin Psychiatry; 2004 Feb 29; 65(2):230-7. PubMed ID: 15003078
    [Abstract] [Full Text] [Related]

  • 18. Maternal use of selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.
    Alwan S, Bandoli G, Chambers CD.
    Clin Pharmacol Ther; 2016 Jul 29; 100(1):34-41. PubMed ID: 27060574
    [Abstract] [Full Text] [Related]

  • 19. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
    Malm H.
    Ther Drug Monit; 2012 Dec 29; 34(6):607-14. PubMed ID: 23042258
    [Abstract] [Full Text] [Related]

  • 20. SSRI antidepressants in utero: pulmonary hypertension.
    Prescrire Int; 2014 Nov 29; 23(154):268. PubMed ID: 25954798
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.